These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 467811)

  • 1. Variation in the disappearance of unlabeled insulin from plasma: studies with portal and peripheral infusions.
    Tranberg KG; Thorell J
    Diabetes; 1979 Sep; 28(9):846-51. PubMed ID: 467811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of plasma disappearance of unlabeled insulin in man.
    Tranberg KG; Dencker H
    Am J Physiol; 1978 Dec; 235(6):E577-85. PubMed ID: 736117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
    Boden G; Essa N; Owen OE; Reichle FA
    J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intraportal and peripheral infusions of glucagon on insulin and glucose concentrations and glucose tolerance in normal man.
    Holst JJ; Madsen OG; Knop J; Schmidt A
    Diabetologia; 1977 Sep; 13(5):487-90. PubMed ID: 908472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.
    Galassetti P; Shiota M; Zinker BA; Wasserman DH; Cherrington AD
    Am J Physiol; 1998 Jul; 275(1):E101-11. PubMed ID: 9688880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin infusion into the portal and peripheral circulations of unanaesthetized dogs.
    Stevenson RW; Parsons JA; Alberti KG
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):335-47. PubMed ID: 647987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic uptake of insulin in man.
    Tranberg KG
    Am J Physiol; 1979 Dec; 237(6):E509-18. PubMed ID: 517648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis RM; Hartley CJ; Entman ML; Field JB
    Diabetes; 1984 Oct; 33(10):984-90. PubMed ID: 6383906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients.
    Vuorinen-Markkola H; Koivisto VA; Yki-Jarvinen H
    Diabetes; 1992 May; 41(5):571-80. PubMed ID: 1568526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma glucose, insulin and increased serum levels during continuous infusion of glucose in low dosages].
    Marshall M; Heigenhauser F; Zöllner N
    Nutr Metab; 1979; 23(1):65-72. PubMed ID: 759995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
    Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
    J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of insulin in man: variation with the plasma insulin level.
    Tranberg KG; Hagander P; Thorell J
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):391-7. PubMed ID: 7020317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.
    Stevenson RW; Orskov H; Parsons JA; Alberti KG
    Am J Physiol; 1983 Aug; 245(2):E200-8. PubMed ID: 6349384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs.
    Stevenson RW; Parsons JA; Alberti KG
    Am J Physiol; 1983 Feb; 244(2):E190-5. PubMed ID: 6337503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM.
    Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD
    Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparsion of the effect of intraportal and intravenous infusion of insulin on blood glucose and free fatty acids in peripheral venous blood of man.
    Erwald R; Hed R; Nygren A; Röjdmark S; Wiechel KL
    Acta Med Scand; 1974 May; 195(5):351-7. PubMed ID: 4830050
    [No Abstract]   [Full Text] [Related]  

  • 19. Counterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans.
    Lewis GF; Carpentier A; Bilinski D; Giacca A; Vranic M
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1037-46. PubMed ID: 10084592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.